EPS with fever versus NMS.
Simpson
G M
GM
D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000175:diagnosis* / Q000517:prevention & control; D018680:Cholinergic Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D003937:Diagnosis, Differential; D018491:Dopamine Agonists / Q000627:therapeutic use; D005260:Female; D005334:Fever / Q000139:chemically induced* / Q000175:diagnosis*; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis* / Q000209:etiology; D018967:Risperidone / Q000009:adverse effects; D013375:Substance Withdrawal Syndrome / Q000209:etiology* / Q000517:prevention & control
D018680:Cholinergic Antagonists; D018491:Dopamine Agonists; D018967:Risperidone